Following anti-tumor responses in melanoma patients vaccinated with autologous DCs

We obtained data on anti-tumor responses in melanoma patients that were vaccinated with autologous DCs loaded with a combination of tumor Ag peptides. This study is a collaboration with the lab of Didier Colau and Thierry Boon in Brussels. HLA-DP4/MAGE3 molecules have been prepared to stain ex vivo PBL from immunized melanoma patients.

• molecule type
• peptide,
• Major histocompatibility complex class II,
• melanoma antigen MAGE-3

• cell type
• dendritic cell

• organism type
• Homo sapiens

• experimental design type
• ex vivo design experiment

• experimental factor type
• Clinical treatment factor

created over 16 years ago (2 March 2009)    last modified over 13 years ago (26 March 2012)   [ RDF ]   [ RelFinder ]